Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Agenus Revenue 2006-2019 | AGEN

Agenus revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Agenus Annual Revenue
(Millions of US $)
2018 $37
2017 $43
2016 $23
2015 $25
2014 $7
2013 $3
2012 $16
2011 $3
2010 $3
2009 $3
2008 $3
2007 $6
2006 $1
2005 $1
Agenus Quarterly Revenue
(Millions of US $)
Q3 2019 $20
Q2 2019 $16
Q1 2019 $80
Q4 2018 $6
Q3 2018 $13
Q2 2018 $16
Q1 2018 $2
Q4 2017 $8
Q3 2017 $3
Q2 2017 $4
Q1 2017 $27
Q4 2016 $6
Q3 2016 $4
Q2 2016 $7
Q1 2016 $6
Q4 2015 $8
Q3 2015 $7
Q2 2015 $6
Q1 2015 $4
Q4 2014 $2
Q3 2014 $2
Q2 2014 $3
Q1 2014 $1
Q4 2013 $0
Q3 2013 $1
Q2 2013 $1
Q1 2013 $1
Q4 2012 $1
Q3 2012 $1
Q2 2012 $1
Q1 2012 $13
Q4 2011 $1
Q3 2011 $1
Q2 2011 $1
Q1 2011 $1
Q4 2010 $1
Q3 2010 $1
Q2 2010 $1
Q1 2010 $1
Q4 2009 $1
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $1
Q3 2008 $1
Q2 2008 $1
Q1 2008 $1
Q4 2007 $1
Q3 2007 $1
Q2 2007 $1
Q1 2007 $2
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.511B $0.037B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.499B 15.15
CSL (CSLLY) Australia $82.574B 0.00
Gilead Sciences (GILD) United States $81.374B 10.08
Celgene (CELG) United States $78.289B 11.18
Biogen (BIIB) United States $52.581B 9.02
Vertex Pharmaceuticals (VRTX) United States $52.423B 53.51
Illumina (ILMN) United States $43.472B 47.70
Regeneron Pharmaceuticals (REGN) United States $38.266B 16.75
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.218B 11.96
Seattle Genetics (SGEN) United States $18.962B 0.00
Incyte (INCY) United States $18.554B 43.07
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.630B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Galapagos (GLPG) Belgium $10.444B 26.91
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Exact Sciences (EXAS) United States $10.375B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.129B 0.00
BeiGene (BGNE) Cayman Islands $9.321B 0.00
Bio-Techne Corp (TECH) United States $7.773B 52.03
Amarin (AMRN) Ireland $7.480B 0.00
Sarepta Therapeutics (SRPT) United States $7.451B 0.00
QIAGEN (QGEN) Netherlands $7.275B 23.72
ACADIA Pharmaceuticals (ACAD) United States $7.136B 0.00
Guardant Health (GH) United States $6.908B 0.00
Moderna (MRNA) United States $5.995B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.662B 14.40
Reata Pharmaceuticals (RETA) United States $5.504B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.856B 0.00
Ascendis Pharma (ASND) Denmark $4.687B 0.00
Exelixis (EXEL) United States $4.661B 13.11
China Biologic Products (CBPO) China $4.538B 28.33
Repligen (RGEN) United States $4.306B 78.04
Spark Therapeutics (ONCE) United States $4.298B 0.00
Medicines (MDCO) United States $4.256B 0.00
Bluebird Bio (BLUE) United States $4.219B 0.00
Mirati Therapeutics (MRTX) United States $4.114B 0.00
Adaptive Biotechnologies (ADPT) United States $3.524B 0.00
Blueprint Medicines (BPMC) United States $3.499B 0.00
Immunomedics (IMMU) United States $3.364B 0.00
MorphoSys AG (MOR) Germany $3.306B 0.00
Alkermes (ALKS) Ireland $3.134B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.958B 0.00
Emergent Biosolutions (EBS) United States $2.856B 28.37
Genmab (GMAB) Denmark $2.834B 5.84
Intercept Pharmaceuticals (ICPT) United States $2.718B 0.00
MyoKardia (MYOK) United States $2.519B 0.00
Halozyme Therapeutics (HALO) United States $2.454B 0.00
NeoGenomics (NEO) United States $2.410B 128.92
Acceleron Pharma (XLRN) United States $2.381B 0.00
UniQure (QURE) Netherlands $2.354B 0.00
Amicus Therapeutics (FOLD) United States $2.350B 0.00
Arena Pharmaceuticals (ARNA) United States $2.313B 5.38
Zai Lab (ZLAB) China $2.242B 0.00
RA PHARMCTL INC (RARX) United States $2.206B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.142B 0.00
Cambrex (CBM) United States $2.018B 25.47
Ligand Pharmaceuticals (LGND) United States $1.905B 36.65
Akcea Therapeutics (AKCA) United States $1.806B 0.00
Myriad Genetics (MYGN) United States $1.800B 26.59
Insmed (INSM) United States $1.697B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.627B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.453B 0.00
Denali Therapeutics (DNLI) United States $1.442B 0.00
REGENXBIO (RGNX) United States $1.405B 0.00
Zymeworks (ZYME) Canada $1.392B 0.00
Epizyme (EPZM) United States $1.369B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.332B 0.00
Coherus BioSciences (CHRS) United States $1.292B 0.00
Innoviva (INVA) United States $1.245B 3.67
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Alector (ALEC) United States $1.123B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.123B 0.00
Sangamo Therapeutics (SGMO) United States $1.115B 0.00
Editas Medicine (EDIT) United States $1.105B 0.00
Fate Therapeutics (FATE) United States $1.097B 0.00
Zealand Pharma (ZEAL) Denmark $1.000B 11.23
WAVE Life Sciences (WVE) Singapore $0.969B 0.00
Athenex (ATNX) United States $0.905B 0.00
Arvinas (ARVN) United States $0.896B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.888B 0.00
Codexis (CDXS) United States $0.888B 0.00
Cara Therapeutics (CARA) United States $0.868B 0.00
Anika Therapeutics (ANIK) United States $0.863B 27.99
Vericel (VCEL) United States $0.858B 320.08
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.796B 6.70
ZIOPHARM Oncology Inc (ZIOP) United States $0.760B 0.00
Principia Biopharma (PRNB) United States $0.749B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Twist Bioscience (TWST) United States $0.729B 0.00
Heska (HSKA) United States $0.722B 184.42
ANI Pharmaceuticals (ANIP) United States $0.701B 11.95
Revance Therapeutics (RVNC) United States $0.684B 0.00
DBV Technologies S.A (DBVT) France $0.683B 0.00
Intellia Therapeutics (NTLA) United States $0.656B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Mesoblast (MESO) Australia $0.610B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
UROGEN PHARMA (URGN) United States $0.575B 0.00
Adverum Biotechnologies (ADVM) United States $0.564B 0.00
Cellectis S.A (CLLS) France $0.564B 0.00
Retrophin (RTRX) United States $0.557B 0.00
BioDelivery Sciences (BDSI) United States $0.524B 0.00
Intra-Cellular Therapies (ITCI) United States $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Kadmon Holdings (KDMN) United States $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
Cytokineticsorporated (CYTK) United States $0.470B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.455B 0.00
PHARMA MAR SA (PHMMF) Spain $0.445B 0.00
Stemline Therapeutics (STML) United States $0.422B 0.00
AC Immune SA (ACIU) Switzerland $0.378B 28.00
Merus (MRUS) Netherlands $0.377B 0.00
Prothena (PRTA) Ireland $0.376B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.373B 2.58
Arcus Biosciences (RCUS) United States $0.369B 0.00
Dynavax Technologies (DVAX) United States $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
PDL BioPharma (PDLI) United States $0.335B 8.37
Bellus Health (BLU) Canada $0.330B 0.00
Puma Biotechnology (PBYI) United States $0.329B 0.00
Kindred Biosciences (KIN) United States $0.323B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.312B 0.00
Pfenex (PFNX) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.305B 0.00
Clovis Oncology (CLVS) United States $0.300B 0.00
Theratechnologies (THTX) Canada $0.299B 0.00
AnaptysBio (ANAB) United States $0.290B 0.00
Geron (GERN) United States $0.288B 0.00
Compugen (CGEN) Israel $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.276B 0.00
Gritstone Oncology (GRTS) United States $0.263B 0.00
Scholar Rock Holding (SRRK) United States $0.259B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
MannKind (MNKD) United States $0.252B 0.00
CytomX Therapeutics (CTMX) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Inovio Pharmaceuticals (INO) United States $0.242B 0.00
Cel-Sci (CVM) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.233B 0.00
Albireo Pharma (ALBO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Kamada (KMDA) Israel $0.221B 8.45
Sorrento Therapeutics (SRNE) United States $0.215B 0.00
Syros Pharmaceuticals (SYRS) United States $0.213B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.210B 0.00
Athersys (ATHX) United States $0.208B 0.00
XOMA (XOMA) United States $0.207B 0.00
Spero Therapeutics (SPRO) United States $0.200B 0.00
Exicure (XCUR) United States $0.196B 0.00
OSMOTICA PHARM (OSMT) United States $0.196B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.190B 0.00
Palatin Technologies (PTN) United States $0.185B 5.43
Senesco Technologies (ELOX) United States $0.175B 0.00
Arsanis (XFOR) United States $0.174B 0.00
ChromaDex (CDXC) United States $0.169B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.167B 0.00
Dyadic (DYAI) United States $0.158B 0.00
Affimed (AFMD) Germany $0.157B 0.00
Alcobra (ARCT) United States $0.156B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.146B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
CorMedix Inc (CRMD) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Ophthotech (ISEE) United States $0.133B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Menlo Therapeutics (MNLO) United States $0.115B 0.00
Abeona Therapeutics (ABEO) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Mersana Therapeutics (MRSN) United States $0.110B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Novavax (NVAX) United States $0.110B 0.00
NantKwest (NK) United States $0.109B 0.00
BioTime (LCTX) United States $0.107B 5.52
PHASEBIO PHARMA (PHAS) United States $0.105B 0.00
OvaScience (MLND) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.095B 0.00
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Strongbridge Biopharma (SBBP) United States $0.090B 2.40
Adaptimmune Therapeutics (ADAP) United Kingdom $0.090B 0.00
Celyad SA (CYAD) Belgium $0.089B 0.00
Aduro Biotech (ADRO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.077B 0.00
Verastem (VSTM) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Trevena (TRVN) United States $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.064B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Orgenesis (ORGS) United States $0.053B 3.42
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.052B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.051B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Curis (CRIS) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Protalix BioTherapeutics (PLX) Israel $0.031B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.97
VIVUS (VVUS) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Celsion (CLSN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TrovaGene (TROV) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00